|
Market Closed -
Hong Kong S.E.
04:08:09 2026-10-02 EDT
|
5-day change | 1st Jan Change | ||
| 18.50 HKD | -1.18% |
|
-2.32% | -43.60% |
| 09-20 | VISEN Pharmaceuticals(SEHK:2561) dropped from S&P Global BMI Index | CI |
| 08-27 | VISEN Pharmaceuticals Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 258M | - | - | |||
| 74.16B | |||||
| 57.39B | |||||
| 47.64B | |||||
| 44.29B | - | - | - | - | - |
| 42.5B |
- Stock Market
- Stocks
- 2561 Stock
- Charts VISEN Pharmaceuticals
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
